These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


106 related items for PubMed ID: 19501468

  • 1. Changes in CCK-4 induced panic after treatment with the GABA-reuptake inhibitor tiagabine are associated with an increase in 3alpha,5alpha-tetrahydrodeoxycorticosterone concentrations.
    Zwanzger P, Eser D, Romeo E, di Michele F, Baghai TC, Pasini A, Padberg F, Rupprecht R.
    Psychoneuroendocrinology; 2009 Nov; 34(10):1586-9. PubMed ID: 19501468
    [Abstract] [Full Text] [Related]

  • 2. Panic induction with cholecystokinin-tetrapeptide (CCK-4) Increases plasma concentrations of the neuroactive steroid 3alpha, 5alpha tetrahydrodeoxycorticosterone (3alpha, 5alpha-THDOC) in healthy volunteers.
    Eser D, di Michele F, Zwanzger P, Pasini A, Baghai TC, Schüle C, Rupprecht R, Romeo E.
    Neuropsychopharmacology; 2005 Jan; 30(1):192-5. PubMed ID: 15467707
    [Abstract] [Full Text] [Related]

  • 3. Effects of the GABA-reuptake inhibitor tiagabine on panic and anxiety in patients with panic disorder.
    Zwanzger P, Eser D, Nothdurfter C, Baghai TC, Möller HJ, Padberg F, Rupprecht R.
    Pharmacopsychiatry; 2009 Nov; 42(6):266-9. PubMed ID: 19924586
    [Abstract] [Full Text] [Related]

  • 4. Effects of tiagabine on cholecystokinin-tetrapeptide (CCK-4)-induced anxiety in healthy volunteers.
    Zwanzger P, Eser D, Padberg F, Baghai TC, Schule C, Rötzer F, Ella R, Möller HJ, Rupprecht R.
    Depress Anxiety; 2003 Nov; 18(3):140-3. PubMed ID: 14625878
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Partial agonism by 3alpha,21-dihydroxy-5beta-pregnan-20-one at the gamma-aminobutyric acidA receptor neurosteroid site.
    Xue BG, Whittemore ER, Park CH, Woodward RM, Lan NC, Gee KW.
    J Pharmacol Exp Ther; 1997 Jun; 281(3):1095-101. PubMed ID: 9190841
    [Abstract] [Full Text] [Related]

  • 10. Plasma concentrations of anxiolytic neuroactive steroids in men with panic disorder.
    Brambilla F, Mellado C, Alciati A, Pisu MG, Purdy RH, Zanone S, Perini G, Serra M, Biggio G.
    Psychiatry Res; 2005 Jun 30; 135(3):185-90. PubMed ID: 15996752
    [Abstract] [Full Text] [Related]

  • 11. GABA(A) receptor-modulating neuroactive steroid composition in patients with panic disorder before and during paroxetine treatment.
    Ströhle A, Romeo E, di Michele F, Pasini A, Yassouridis A, Holsboer F, Rupprecht R.
    Am J Psychiatry; 2002 Jan 30; 159(1):145-7. PubMed ID: 11772707
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Neuroactive steroids and GABAA receptor plasticity in the brain of the WAG/Rij rat, a model of absence epilepsy.
    Pisu MG, Mostallino MC, Dore R, Mura ML, Maciocco E, Russo E, De Sarro G, Serra M.
    J Neurochem; 2008 Sep 30; 106(6):2502-14. PubMed ID: 18624910
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Changes in neuroactive steroid secretion associated with CO2-induced panic attacks in normal individuals.
    Brambilla F, Perini G, Serra M, Pisu MG, Zanone S, Toffanin T, Milleri S, Garcia CS, Biggio G.
    Psychoneuroendocrinology; 2013 Oct 30; 38(10):2234-42. PubMed ID: 23702252
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Neuroactive steroids in affective disorders: target for novel antidepressant or anxiolytic drugs?
    Schüle C, Eser D, Baghai TC, Nothdurfter C, Kessler JS, Rupprecht R.
    Neuroscience; 2011 Sep 15; 191():55-77. PubMed ID: 21439354
    [Abstract] [Full Text] [Related]

  • 20. Tiagabine improves panic and agoraphobia in panic disorder patients.
    Zwanzger P, Baghai TC, Schüle C, Minov C, Padberg F, Möller HJ, Rupprecht R.
    J Clin Psychiatry; 2001 Aug 15; 62(8):656-7. PubMed ID: 11561942
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.